1、MARCH2026Summary Highlights from a Multi-Stakeholder Panel Discussion at the 13th Annual Emirates Oncology Conference in November 2025Advancing Equitable and Timely Access to Personalized Oncology Therapies:Middle East and Africa SUMMARYTable of Contents2026 IQVIA and its affiliates.All reproduction
2、 rights,quotations,broadcasting,publications reserved.No part of this publication may be reproduced or transmitted in any form or by any means,electronic or mechanical,including photocopy,recording,or any information storage and retrieval system,without express written consent of IQVIA and the IQVIA
3、 Institute.REFERENCING THIS REPORTPlease use this format when referencing content from this report:Source:IQVIA Institute for Human Data Science.Advancing Equitable and Timely Access to Personalized Oncology Therapies:Middle East and Africa.March 2026.Advancing Equitable and Timely Access to Persona
4、lized Oncology Therapies:Middle East and Africa.Panelists 1 Introduction 2Background 2Highlights from the panel discussion 3 Barriers to oncology therapy access across regions 3 Ongoing initiatives and solutions to improve access 4A call-to-action 6References 7About the Institute 8iqviainstitute.org
5、|1PanelistsEXTERNAL SPEAKERSH.E.DR.MOUZA BIN HAMROUR AL AMERIBreast Surgeon,Chief of Breast Care Center,Tawam Hospital/SEHADR.KHALED ABDEL-AZIZ KAMAL Consultant of Clinical Oncology at Ain Shams University,Executive Director of the Presidential Initiative for Cancer Early Detection and Management DR
6、.MOHAMMAD AL NAHEDH Director,Pharmaceutical Care Division,Clinical Pharmacy Consultant,Hematology/Oncology,King Faisal Specialist Hospital and Research Center DR.JACQUES SNYMAN Director and owner of Forte Research Co.(Pty)Ltd,Consultant for Pharmacology Research and HTAMODERATORMURRAY AITKENExecutiv